HYPR
Price
$1.26
Change
+$0.10 (+8.62%)
Updated
Aug 11, 03:28 PM (EDT)
Capitalization
90.29M
2 days until earnings call
JNDOF
Price
$22.75
Change
-$3.25 (-12.50%)
Updated
Oct 13 closing price
Capitalization
1.29B
Interact to see
Advertisement

HYPR vs JNDOF

Header iconHYPR vs JNDOF Comparison
Open Charts HYPR vs JNDOFBanner chart's image
Hyperfine
Price$1.26
Change+$0.10 (+8.62%)
Volume$2.38K
Capitalization90.29M
Jins
Price$22.75
Change-$3.25 (-12.50%)
Volume$300
Capitalization1.29B
HYPR vs JNDOF Comparison Chart in %
Loading...
HYPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HYPR vs. JNDOF commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYPR is a Hold and JNDOF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (HYPR: $1.16 vs. JNDOF: $22.75)
Brand notoriety: HYPR and JNDOF are both not notable
HYPR represents the Medical/Nursing Services, while JNDOF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HYPR: 28% vs. JNDOF: 100%
Market capitalization -- HYPR: $90.29M vs. JNDOF: $1.29B
HYPR [@Medical/Nursing Services] is valued at $90.29M. JNDOF’s [@Pharmaceuticals: Other] market capitalization is $1.29B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $233.71B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.51B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.52B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYPR’s FA Score shows that 0 FA rating(s) are green whileJNDOF’s FA Score has 1 green FA rating(s).

  • HYPR’s FA Score: 0 green, 5 red.
  • JNDOF’s FA Score: 1 green, 4 red.
According to our system of comparison, HYPR is a better buy in the long-term than JNDOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HYPR’s TA Score shows that 2 TA indicator(s) are bullish.

  • HYPR’s TA Score: 2 bullish, 4 bearish.

Price Growth

HYPR (@Medical/Nursing Services) experienced а +12.62% price change this week, while JNDOF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.03%. For the same industry, the average monthly price growth was +0.41%, and the average quarterly price growth was +3.73%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.86%. For the same industry, the average monthly price growth was -3.35%, and the average quarterly price growth was +2.88%.

Reported Earning Dates

HYPR is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Medical/Nursing Services (-2.03% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+1.86% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNDOF($1.29B) has a higher market cap than HYPR($90.3M). HYPR YTD gains are higher at: 31.818 vs. JNDOF (0.000). JNDOF has higher annual earnings (EBITDA): 13.3B vs. HYPR (-42.5M). JNDOF has more cash in the bank: 11.4B vs. HYPR (33.1M). HYPR has less debt than JNDOF: HYPR (263K) vs JNDOF (5.61B). JNDOF has higher revenues than HYPR: JNDOF (89.8B) vs HYPR (11.7M).
HYPRJNDOFHYPR / JNDOF
Capitalization90.3M1.29B7%
EBITDA-42.5M13.3B-0%
Gain YTD31.8180.000-
P/E RatioN/A47.34-
Revenue11.7M89.8B0%
Total Cash33.1M11.4B0%
Total Debt263K5.61B0%
FUNDAMENTALS RATINGS
JNDOF: Fundamental Ratings
JNDOF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
62
PRICE GROWTH RATING
1..100
70
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HYPRJNDOF
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
67%
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
6%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
4%
Advances
ODDS (%)
Bullish Trend 19 days ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
81%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
63%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HYPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WCMIX26.370.01
+0.04%
WCM Focused International Growth Instl
NDVIX17.09N/A
N/A
MFS New Discovery Value I
BRSUX14.31-0.02
-0.14%
MFS Blended Research Small Cap Eq R4
NMFIX13.68-0.05
-0.36%
Northern Multi-Mgr Glbl Listed Infra
RSMOX24.13-0.37
-1.51%
Victory RS Mid Cap Growth A

HYPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYPR has been loosely correlated with JNDOF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPR jumps, then JNDOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPR
1D Price
Change %
HYPR100%
+0.87%
JNDOF - HYPR
43%
Loosely correlated
N/A
SGHT - HYPR
33%
Loosely correlated
+19.44%
RPID - HYPR
26%
Poorly correlated
+1.49%
NXL - HYPR
26%
Poorly correlated
-3.44%
TWST - HYPR
26%
Poorly correlated
+2.56%
More

JNDOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNDOF has been closely correlated with SGHT. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if JNDOF jumps, then SGHT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNDOF
1D Price
Change %
JNDOF100%
N/A
SGHT - JNDOF
75%
Closely correlated
+19.44%
ALGN - JNDOF
60%
Loosely correlated
+2.18%
HYPR - JNDOF
43%
Loosely correlated
+0.87%
ATEC - JNDOF
33%
Poorly correlated
+0.47%
SDMHF - JNDOF
29%
Poorly correlated
+2.48%
More